EyePoint Pharmaceuticals (EYPT) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of$0.77. This compares to a loss of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10.39$0.67 per share when it actually produced a loss of $0.85, delivering a surprise of -26.87%.Over the last f ...